Melatonin prevents age-related hearing loss in the murin experimental model
Braz. j. otorhinolaryngol. (Impr.)
; 88(supl.3): 103-108, Nov.-Dec. 2022. graf
Article
en En
|
LILACS-Express
| LILACS
| ID: biblio-1420834
Biblioteca responsable:
BR1.1
ABSTRACT
Abstract Objective:
The present study aimed to perform a morphological and morphometric analysis of cochlear structures of C57BL/6J mice receiving oral melatonin for a 12-month period.Methods:
32 male C57BL/6J were divided into control and melatonin groups. Control received saline and ethanol solution and melatonin group, 50 μL of 10 mg of melatonin/kg/day orally for a 12-month period. After de experiment the animals were sacrificed into a 40% concentration of CO2 chamber, and the blades were morphological and morphometrically analyzed.Results:
The melatonin group revealed a higher median density of viable cells (45 ± 10.28 cells/100 μm2, 31-73, vs. 32 ± 7.47 cells/100 μm2, 25-48). The median area of stria vascularis was 55.0 ± 12.27 cells/100 μm2 (38-80) in the control, and 59.0 ± 16.13 cells/100 μm2 (40-134) in the melatonin group. The morphometric analysis of the spiral ligament reveals a higher median of total viable neurons in the melatonin (41 ± 7.47 cells/100 μm2, 27-60) than in the control group (31 ± 5.68 cells/100 μm2, 21-44).Conclusion:
Although melatonin is a potent antioxidant, it does not completely neutralize the occurrence of presbycusis; however, it may delay the onset of this condition. Level of evidence 3.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
LILACS
Idioma:
En
Revista:
Braz. j. otorhinolaryngol. (Impr.)
Asunto de la revista:
OTORRINOLARINGOLOGIA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Brasil